Jennifer King
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase II Trial of Cabozantinib With Patients With Refractory GCTs (NCT04876456) | Jennifer King | 2021-06-10 |
Track Jennifer King automatically
Every clearance here is in the API, with alerts when new ones post.